The Role of the Immune System in Systemic Sclerosis
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 1836
Special Issue Editor
Interests: systemic sclerosis; B cells; T cells; psoriasis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Systemic sclerosis is a systemic inflammatory disease that begins with immune abnormalities and leads to vascular damage and fibrosis. Although basic research has typically focused on B cells, vascular endothelial cells, and fibroblasts, systemic sclerosis research has made rapid progress, especially in recent years. Reasons for these advances include technological advances such as single cell analysis, as well as advances in clinical and translational research. These rapid advances have left no doubt surrounding the involvement of inflammatory cytokines and immune abnormalities in the pathogenesis of systemic sclerosis. This Special Issue, entitled "The Role of the Immune System in Systemic Sclerosis", aims to advance research on the involvement of the immune system in systemic sclerosis research.
Dr. Takemichi Fukasawa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- systemic sclerosis
- interstitial lung disease
- pulmonary hypertension
- ulcer
- comorbidities
- B cells
- T cells
- macrophages
- translational research
- basic research
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
